Abstract
ObjectiveThe aim of this study was to assess the efficacy and safety of adalimumab (ADA), a recombinant human monoclonal antibody against tumour necrosis factor α (TNF), for the induction of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have